Shanghai MicroPort EP MedTech Co., Ltd. (688351.SS)
- Previous Close
25.98 - Open
26.00 - Bid 25.46 x --
- Ask 25.49 x --
- Day's Range
25.25 - 26.00 - 52 Week Range
15.44 - 28.75 - Volume
1,013,203 - Avg. Volume
1,562,444 - Market Cap (intraday)
11.996B - Beta (5Y Monthly) --
- PE Ratio (TTM)
637.25 - EPS (TTM)
0.04 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
26.97
Shanghai MicroPort EP Medtech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy. The company offers Columbus 3D EP navigation systems and cardiac electrophysiology stimulators; FireMagic 3D irrigated and cardiac RF ablation catheters; EasyLoop circular mapping catheters; and PathBuilder steerable introducers, transseptal guiding introducers, and transseptal needles. It also provides EasyLoop circular mapping catheters; and EasyFinder fixed and steerable curve diagnostic catheters. The company was formerly known as Shanghai Wei Chuang Electrophysiology Medical Technology Co., Ltd. and changed its name to Shanghai MicroPort EP Medtech Co., Ltd. in April 2016. Shanghai MicroPort EP Medtech Co., Ltd. was founded in 2010 and is based in Shanghai, the People's Republic of China.
www.everpace.comRecent News: 688351.SS
Performance Overview: 688351.SS
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688351.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688351.SS
Valuation Measures
Market Cap
12.00B
Enterprise Value
10.68B
Trailing P/E
624.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
32.68
Price/Book (mrq)
7.09
Enterprise Value/Revenue
29.17
Enterprise Value/EBITDA
526.54
Financial Highlights
Profitability and Income Statement
Profit Margin
5.24%
Return on Assets (ttm)
-0.76%
Return on Equity (ttm)
1.14%
Revenue (ttm)
366.21M
Net Income Avi to Common (ttm)
19.18M
Diluted EPS (ttm)
0.04
Balance Sheet and Cash Flow
Total Cash (mrq)
1.34B
Total Debt/Equity (mrq)
1.42%
Levered Free Cash Flow (ttm)
-46.72M
Research Analysis: 688351.SS
Company Insights: 688351.SS
688351.SS does not have Company Insights